Skip to content

Stellate Ganglion Blockade to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors

A Pilot Study of Stellate Ganglion Blockade + Psychoeducation to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04582396
Acronym
SGB-PsychoED
Enrollment
1
Registered
2020-10-09
Start date
2021-03-11
Completion date
2021-04-19
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and Fear, Cardiac Arrest, Health Behavior, PTSD, Sleep Disturbance

Brief summary

This is a pilot randomized controlled trial (RCT) to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade (SGB) and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD symptoms after cardiac arrest (CA). Primary Aim 1 (Feasibility outcomes): Gain preliminary evidence regarding the acceptability, tolerability, and safety of conducting a randomized trial that evaluates a single SGB treatment in conjunction with psychoeducation among CA patients with early PTSD symptoms. Secondary Aim 1 (Treatment-related outcomes): Test, whether SGB/psychoeducation treatment in CA patients with clinically significant PTSD symptoms is associated with reduced cardiac anxiety, PTSD symptoms, and improved health behaviors (physical activity and sleep duration), assessed objectively by a wrist-worn accelerometer for 4 weeks post-discharge.

Detailed description

Every year in the U.S., 500,000 people experience sudden cardiac arrest (CA), caused by electrical disturbances across cardiac tissue, leading to marked arrhythmia that ultimately results in the heart ceasing to pump blood to the brain, lungs, and other organs. Due to advances in bundled post-arrest care, cardio-cerebral resuscitation, and effective cooling protocols, a substantial proportion of patients who receive guideline-based care (nearly 1 in 3 for out-of-hospital and \ 50% for in-hospital CA) now survive this once universally fatal condition. While most survivors retain their cognitive function and physical independence, many grapple with CA's psychological consequences in the context of learning that they were clinically dead. In particular, many describe the CA experience as traumatic, and up to 1 in 3 CA survivors subsequently develop posttraumatic stress disorder (PTSD). Not only is PTSD common in CA patients, but there is evidence that PTSD after CA may influence health behaviors and prognosis. Treatment of early PTSD and cardiac anxiety symptoms after CA requires timely intervention. Recent studies show that SGB is a safe and acceptable intervention for reducing PTSD symptoms in combat veterans. SGB treatment has never been tested to treat PTSD induced by acute medical events such as CA.

Interventions

PROCEDUREstellate ganglion block injection

A stellate ganglion block (SGB) is an injection of local anesthetic (numbing medicine) to block the nerves located on either side of the voice box in the neck. It will be administered in an inpatient monitored setting.

PROCEDURENormal saline injection

An injection of normal saline will be injected into muscle on either side of the voice box in the neck. It will be administered in an inpatient monitored setting.

BEHAVIORALPsychoeducation

The session will be 30 minutes in duration, to be administered by a health professional with experience working with CA patients, the goal will be to establish rapport and help patient identify anxious situations, thoughts, and bodily feelings related their recent CA that could lead to avoidant behavior. Explain how many of these feelings are common in CA survivors, and they are often unrelated to their risk of its recurrence. Explain how the body has a fight-or-flight system that is controlled in part by the stellate ganglion and explain how blocking the action of this part of the body can reduce the feelings of anxiety that commonly occur. Discuss how certain activities such as exercise can increase feelings of anxiety around bodily sensations, but continued engagement could reduce that fear and that exercise is helpful for recovering from CA

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

In addition to the unblinded coordinator, and due to the nature of the study treatment, the person performing the procedure cannot be blinded (i.e. the person performing the procedure needs to assess the effectiveness of the block objective physical signs and symptoms), but is encouraged not to disclose the allocation to the patient or outcome assessors either before or after the procedure.

Intervention model description

This is a pilot RCT to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade and psychoeducation vs sham-procedure and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD symptoms after cardiac arrest.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18 years or older 2. Fluent in English or Spanish 3. A diagnosis of cardiac arrest (CA) 4. Admitted to the New York-Presbyterian Hospital 5. Elevated symptoms of psychological distress a. PCL-5 \> 32 with a minimum of 2 weeks after cardiac arrest

Exclusion criteria

1. A prior SGB treatment 2. Severe brain injury defined as Cerebral Performance Category Score ≥3, and/or significant aphasia, dysarthria, or cognitive impairment precluding ability to complete study questionnaires as determined by interviewer 3. Terminal non-cardiovascular illness (life expectancy \<1 year) 4. Severe mental illness requiring urgent psychiatric hospitalization 5. Alcohol or substance abuse that would impede ability to complete study 6. Unavailable for telephone and in-person follow-up 7. Allergy to amide local anesthetics (e.g., ropivacaine, bupivacaine) 8. Pre-existing Horner's syndrome 9. Pregnancy 10. Current anticoagulant use 11. History of a bleeding disorder 12. Infection or mass at injection site

Design outcomes

Primary

MeasureTime frameDescription
Total Actigraph Wear TimeAssessed at 4-weeks post-procedurethe proportion of participants with \>80% of the total actigraph wear time. It is designed to assess the acceptability of actigraphy
Number of Patients Recruited Per MonthAssessed at 10 Month from the beginning of enrollmentThis is designed to measure the rate of enrollment, with \<4 patients/month considered not meeting outcome
Proportion of Participants Who Complete the 4-weeks Assessments4 weeks post-enrollmentThis is designed to assess the short-term attrition and lost to follow-up up to 4 weeks post-enrollment.
Proportion of Participants Who Complete the 12-weeks Assessments12-weeks post-procedureThis is designed to assess the long-term attrition and lost to follow-up up to 12 weeks post-enrollment.
Horner's SyndromeImmediately post-procedureHorner syndrome is a condition that affects the face and eye on one side of the body, being caused by a disrupted nerve pathway from the brain to the head and neck. This syndrome can be assessed through a visual exam, involving the observation of decreased pupil size, a drooping eyelid and decreased sweating on the affected side of the face.
Treatment Expectancy Eligibility QuestionnaireImmediately post-procedureThis is a questionnaire that assesses the number of participants with credibility. Through this questionnaire, whether the participant will proceed through the study will be determined.
The Proportion of Participants Completing the Check-list of Various Components of PsychoeducationAssessed at baseline post-procedureThis is designed to assess the feasibility of administering psychoeducation, with \>80% of the components in the checklist as a threshold for success.
Proportion of Eligible Subjects Who Get Enrolled in the TrialBaseline (pre-procedure)This is designed to measure the feasibility of successful enrollment.

Secondary

MeasureTime frameDescription
The Proportion of Participants With Clinically Significant Symptoms of Cardiac AnxietyAssessed pre-procedure and then repeated at 4-weeks post-procedureThe effect of SGB-PsychoED intervention on cardiac anxiety will be assessed using cardiac anxiety questionnaire (CAQ).This is an 18-item questionnaire that assesses anxiety through three divided sub-scales: fear (items 10, 11, 13-18), avoidance (items 2, 5, 7, 9, 12), and attention (items 1, 3, 4, 6, 8). Each item is scored via the 5-point Likert scale: Never (0), Rarely (1). Sometimes (2), Often (3), and Always (4). Item responses are summed to receive a score between 0-72. Higher reported scores indicate a greater heart-focused anxiety.
The Proportion of Participants With Clinically Significant Symptoms of Generalized Anxiety Disorder.Assessed pre-procedure and then repeated at 4-weeks post-procedureThe effect of the intervention on generalized anxiety disorder will be assessed using the generalized anxiety disorder scale-7 (GAD-7). This is a 7-item scale that assesses the presence of generalized anxiety disorder. Responses can be given as Not at all (0), Several days (1), More than half the days (2), and Nearly every day (3). These scores can be summed to produce a score between 0 and 21. Scores between 0-4 indicate minimal anxiety, scores between 5-9 indicate mild anxiety, scores between 10-14 indicate moderate anxiety, and scores greater than 15 indicate severe anxiety.
The Proportion of Participants With Clinically Significant Symptoms of Depression.Assessed pre-procedure and then repeated at 4-weeks post-procedureThe effect of SGB-PsychoED intervention on depression will be assessed using the eight-item Patient Health Questionnaire depression scale (PHQ-8). This is an 8-item scale that assesses depression, with responses to each item being: Not at all (0), Several days (1), More than half the days (2), and Nearly every day (3). The sub-scores are summed to result in a score from 0-24. Higher scores indicate higher indication of depression. Scores that are reported as 10 or above are assessed to be showing symptoms of depression.
The Proportion of Participants With Moderate to High Levels of Physical Activity.Assessed at 4-weeks post-dischargeEffect of SGB-PsychoED intervention on mean minutes/day of physical activity as measured by the objective actigraphy data
The Proportion of Participants With Reduced Duration of Sleep.Assessed at 4-weeks post-dischargeEffect of SGB-PsychoED intervention on mean hours/day of sleep as measured by the objective actigraphy data
Number of Participants With Posttraumatic Stress Disorder Using Posttraumatic Stress Disorder (PCL-5)Assessed pre-procedure and then repeated at 4-weeks post-procedureThis is a 20-item self-report measure that assesses symptoms of PTSD. Each item can be scored on a scale of 0-4, Not at all (0), A little bit (1), Moderately (2), Quite a bit (3), and Extremely (4) are the eligible responses. There are five clusters that are assessed: items 1-5, items 6-7, items 8-14, and items 15-20. Each of these sub-scores are summed to receive a score between 0-80; a higher score indicating a higher severity of PTSD symptoms. The cutoff score that is indicative of probable PTSD is 31-33.

Countries

United States

Participant flow

Participants by arm

ArmCount
Stellate Ganglion Block + Psychoeducation
For the active SGB arm, 7 to 8 mL of ropivacaine, 0.5%, will be injected around and into the site of the ganglion once before the hospital discharge. They will also receive a 30 minutes session of psychoeducation by a health professional with experience working with CA patients. stellate ganglion block injection: A stellate ganglion block (SGB) is an injection of local anesthetic (numbing medicine) to block the nerves located on either side of the voice box in the neck. It will be administered in an inpatient monitored setting. Psychoeducation: The session will be 30 minutes in duration, to be administered by a health professional with experience working with CA patients, the goal will be to establish rapport and help patient identify anxious situations, thoughts, and bodily feelings related their recent CA that could lead to avoidant behavior. Explain how many of these feelings are common in CA survivors, and they are often unrelated to their risk of its recurrence. Explain how the body has a fight-or-flight system that is controlled in part by the stellate ganglion and explain how blocking the action of this part of the body can reduce the feelings of anxiety that commonly occur. Discuss how certain activities such as exercise can increase feelings of anxiety around bodily sensations, but continued engagement could reduce that fear and that exercise is helpful for recovering from CA
0
Normal Saline Injection + Psychoeducation
For the sham procedure, 1 to 2 mL of preservative-free normal saline will be injected into deep musculature in the neck. They will also receive a 30 minutes session of psychoeducation by a health professional with experience working with CA patients. Normal saline injection: An injection of normal saline will be injected into muscle on either side of the voice box in the neck. It will be administered in an inpatient monitored setting. Psychoeducation: The session will be 30 minutes in duration, to be administered by a health professional with experience working with CA patients, the goal will be to establish rapport and help patient identify anxious situations, thoughts, and bodily feelings related their recent CA that could lead to avoidant behavior. Explain how many of these feelings are common in CA survivors, and they are often unrelated to their risk of its recurrence. Explain how the body has a fight-or-flight system that is controlled in part by the stellate ganglion and explain how blocking the action of this part of the body can reduce the feelings of anxiety that commonly occur. Discuss how certain activities such as exercise can increase feelings of anxiety around bodily sensations, but continued engagement could reduce that fear and that exercise is helpful for recovering from CA
1
Total1

Baseline characteristics

CharacteristicNormal Saline Injection + PsychoeducationTotal
Age, Categorical
<=18 years
0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants1 Participants
Cardiac Anxiety Questionnaire19 units on a scale19 units on a scale
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Generalized Anxiety Disorder Scale - 7 questions11 units on a scale11 units on a scale
Patient Health Questionnaire depression scale- 8 items6 units on a scale6 units on a scale
Posttraumatic Stress Disorder Scale43 units on a scale43 units on a scale
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants
Race (NIH/OMB)
White
0 Participants0 Participants
Region of Enrollment
United States
1 participants1 participants
Sex: Female, Male
Female
0 Participants0 Participants
Sex: Female, Male
Male
1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 1
other
Total, other adverse events
0 / 01 / 1
serious
Total, serious adverse events
0 / 00 / 1

Outcome results

Primary

Horner's Syndrome

Horner syndrome is a condition that affects the face and eye on one side of the body, being caused by a disrupted nerve pathway from the brain to the head and neck. This syndrome can be assessed through a visual exam, involving the observation of decreased pupil size, a drooping eyelid and decreased sweating on the affected side of the face.

Time frame: Immediately post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, 10 were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsHorner's Syndrome1 Participants
Primary

Number of Patients Recruited Per Month

This is designed to measure the rate of enrollment, with \<4 patients/month considered not meeting outcome

Time frame: Assessed at 10 Month from the beginning of enrollment

Population: During the enrollment period, 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, 10 were prescribed anticoagulants, rendering them ineligible for the study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsNumber of Patients Recruited Per Month1 Participants
Primary

Proportion of Eligible Subjects Who Get Enrolled in the Trial

This is designed to measure the feasibility of successful enrollment.

Time frame: Baseline (pre-procedure)

Population: During the enrollment period, 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, 10 were prescribed anticoagulants, rendering them ineligible for the study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsProportion of Eligible Subjects Who Get Enrolled in the Trial1 Participants
Primary

Proportion of Participants Who Complete the 12-weeks Assessments

This is designed to assess the long-term attrition and lost to follow-up up to 12 weeks post-enrollment.

Time frame: 12-weeks post-procedure

Population: There were no participants randomized to the Stellate Ganglion Block + Psychoeducation arm

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsProportion of Participants Who Complete the 12-weeks Assessments1 Participants
Primary

Proportion of Participants Who Complete the 4-weeks Assessments

This is designed to assess the short-term attrition and lost to follow-up up to 4 weeks post-enrollment.

Time frame: 4 weeks post-enrollment

Population: There were no participants randomized to the Stellate Ganglion Block + Psychoeducation arm

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsProportion of Participants Who Complete the 4-weeks Assessments1 Participants
Primary

The Proportion of Participants Completing the Check-list of Various Components of Psychoeducation

This is designed to assess the feasibility of administering psychoeducation, with \>80% of the components in the checklist as a threshold for success.

Time frame: Assessed at baseline post-procedure

Population: There were no participants randomized to the Stellate Ganglion Block + Psychoeducation arm

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants Completing the Check-list of Various Components of Psychoeducation1 Participants
Primary

Total Actigraph Wear Time

the proportion of participants with \>80% of the total actigraph wear time. It is designed to assess the acceptability of actigraphy

Time frame: Assessed at 4-weeks post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsTotal Actigraph Wear Time1 Participants
Primary

Treatment Expectancy Eligibility Questionnaire

This is a questionnaire that assesses the number of participants with credibility. Through this questionnaire, whether the participant will proceed through the study will be determined.

Time frame: Immediately post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsTreatment Expectancy Eligibility Questionnaire1 Participants
Secondary

Number of Participants With Posttraumatic Stress Disorder Using Posttraumatic Stress Disorder (PCL-5)

This is a 20-item self-report measure that assesses symptoms of PTSD. Each item can be scored on a scale of 0-4, Not at all (0), A little bit (1), Moderately (2), Quite a bit (3), and Extremely (4) are the eligible responses. There are five clusters that are assessed: items 1-5, items 6-7, items 8-14, and items 15-20. Each of these sub-scores are summed to receive a score between 0-80; a higher score indicating a higher severity of PTSD symptoms. The cutoff score that is indicative of probable PTSD is 31-33.

Time frame: Assessed pre-procedure and then repeated at 4-weeks post-procedure

Population: There were no participants randomized to the Stellate Ganglion Block + Psychoeducation arm

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsNumber of Participants With Posttraumatic Stress Disorder Using Posttraumatic Stress Disorder (PCL-5)1 Participants
Secondary

The Proportion of Participants With Clinically Significant Symptoms of Cardiac Anxiety

The effect of SGB-PsychoED intervention on cardiac anxiety will be assessed using cardiac anxiety questionnaire (CAQ).This is an 18-item questionnaire that assesses anxiety through three divided sub-scales: fear (items 10, 11, 13-18), avoidance (items 2, 5, 7, 9, 12), and attention (items 1, 3, 4, 6, 8). Each item is scored via the 5-point Likert scale: Never (0), Rarely (1). Sometimes (2), Often (3), and Always (4). Item responses are summed to receive a score between 0-72. Higher reported scores indicate a greater heart-focused anxiety.

Time frame: Assessed pre-procedure and then repeated at 4-weeks post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants With Clinically Significant Symptoms of Cardiac Anxiety1 Participants
Secondary

The Proportion of Participants With Clinically Significant Symptoms of Depression.

The effect of SGB-PsychoED intervention on depression will be assessed using the eight-item Patient Health Questionnaire depression scale (PHQ-8). This is an 8-item scale that assesses depression, with responses to each item being: Not at all (0), Several days (1), More than half the days (2), and Nearly every day (3). The sub-scores are summed to result in a score from 0-24. Higher scores indicate higher indication of depression. Scores that are reported as 10 or above are assessed to be showing symptoms of depression.

Time frame: Assessed pre-procedure and then repeated at 4-weeks post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants With Clinically Significant Symptoms of Depression.1 Participants
Secondary

The Proportion of Participants With Clinically Significant Symptoms of Generalized Anxiety Disorder.

The effect of the intervention on generalized anxiety disorder will be assessed using the generalized anxiety disorder scale-7 (GAD-7). This is a 7-item scale that assesses the presence of generalized anxiety disorder. Responses can be given as Not at all (0), Several days (1), More than half the days (2), and Nearly every day (3). These scores can be summed to produce a score between 0 and 21. Scores between 0-4 indicate minimal anxiety, scores between 5-9 indicate mild anxiety, scores between 10-14 indicate moderate anxiety, and scores greater than 15 indicate severe anxiety.

Time frame: Assessed pre-procedure and then repeated at 4-weeks post-procedure

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants With Clinically Significant Symptoms of Generalized Anxiety Disorder.1 Participants
Secondary

The Proportion of Participants With Moderate to High Levels of Physical Activity.

Effect of SGB-PsychoED intervention on mean minutes/day of physical activity as measured by the objective actigraphy data

Time frame: Assessed at 4-weeks post-discharge

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants With Moderate to High Levels of Physical Activity.1 Participants
Secondary

The Proportion of Participants With Reduced Duration of Sleep.

Effect of SGB-PsychoED intervention on mean hours/day of sleep as measured by the objective actigraphy data

Time frame: Assessed at 4-weeks post-discharge

Population: 11 patients reported elevated PTSD and/or cardiac anxiety scores (an initial eligibility requirement for our study). Of these 11 patients, we learned that a majority (10 out of 11) were prescribed anticoagulants, rendering them ineligible for our study since one of the exclusion criteria is current anticoagulant use. One patient was enrolled and completed all study procedures.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsThe Proportion of Participants With Reduced Duration of Sleep.1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026